BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 70771)

  • 1. Immunodiagnostics of malignant diseases. II. The electrophoretic mobility test in the diagnosis of gynecological malignancies.
    Douwes FR; Hoffmann W; Mross K
    Oncology; 1977; 34(2):80-3. PubMed ID: 70771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
    Hoffmann W; Werner W; Steiner R; Kaufmann R
    Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
    Günther J
    Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune diagnosis of malignant diseases. X. Value of the electrophoresis mobility test in the diagnosis of broncho-pulmonary diseases].
    Douwes FR
    Onkologie; 1978 Apr; 1(2):79-84. PubMed ID: 82241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
    Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
    Oncology; 1978; 35(4):163-7. PubMed ID: 81476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
    Jenssen HL; Köhler H; Günther J; Klausch B; Straube W; Hofmann R; Büttner HH
    Arch Gynakol; 1976 Mar; 220(3):191-8. PubMed ID: 773334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Photographic evaluation of the electrophoretic mobility test. A modification].
    Wagner G; Winter G
    Onkologie; 1982 Jun; 5(3):135-44. PubMed ID: 6750483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunodiagnosis of malignant disease. I. The electrophoresis-mobility test in the diagnosis of bronchial carcinoma (author's transl)].
    Douwes FR; Hüttemann U; Mross K
    Dtsch Med Wochenschr; 1977 Mar; 102(12):419-22. PubMed ID: 321201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunity to human basic myelin protein in women with dysplasia and carcinoma in situ of the cervix.
    Singer A; Shelton J; Hill S; Potter C
    Br J Obstet Gynaecol; 1975 Oct; 82(10):820-5. PubMed ID: 53067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evidence that electrophoretic-mobility (EM) test is of no value for the diagnosis of cancer in children (author's transl)].
    Lasson U; Scherer G; Müller-Ruchholtz W
    Monatsschr Kinderheilkd; 1981 Mar; 129(3):164-7. PubMed ID: 6112683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test.
    Lampert F; Nitzschke U; Zwergel T
    Br J Cancer; 1977 Jun; 35(6):844-9. PubMed ID: 68784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electrophoresis mobility inhibition test (emt) in immunological early diagnosis of gynaecological malignomas (author's transl)].
    Kreienberg R; Schütz G; Melchert F; Lemmel EM
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):709-15. PubMed ID: 383565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].
    Tautz C; Schneider W; Laier E; Brügmann G
    Klin Wochenschr; 1978 Feb; 56(4):175-85. PubMed ID: 75286
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrophage electrophoretic mobility (MEM) with myelin basic protein.
    Rawlins GA; Wood JM; Bagshawe KD
    Br J Cancer; 1976 Dec; 34(6):613-8. PubMed ID: 1008988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
    Harlos JP; Weiss L
    Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study about the use of LAI test and MI test in immunodiagnostics of gynecological tumours (author's transl)].
    Jandová A; Svec M; Heyberger K; Laurová L; Novotná J; Roubal J; Trnka V; Vancurik J
    Cesk Gynekol; 1979 Feb; 44(1):44-50. PubMed ID: 371825
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrophoretic mobility test for lymphocyte sensitization using tanned sheep erythrocytes.
    Jenssen HL; Shenton BK
    Acta Biol Med Ger; 1975; 34(4):K 29-32. PubMed ID: 1237979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electrophoretic mobility test with myelin basic protein, binding of 125I-MBP to lymphocytes, and gel electrophoresis pattern of supernatant during incubation.
    Mross K; Mross B; Wolfrum DI; Kohlschütter A
    Res Exp Med (Berl); 1980; 177(3):245-53. PubMed ID: 6160602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leukocyte migration inhibition test using myelin basic protein in patients with malignant diseases].
    Mross K; Mross B; Wolfrum DI
    Onkologie; 1982 Jun; 5(3):130-4. PubMed ID: 6181442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Leukocyte migration inhibition in women with tumors in an environment with ovarian carcinoma antigen and encephalitogenic factor].
    Tosner J; Fixa B
    Cas Lek Cesk; 1984 Mar; 123(12):354-7. PubMed ID: 6085556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.